Recent updates of centromere proteins in hepatocellular carcinoma: a review
Abstract Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide, with approximately 800,000 deaths worldwide each year. Owing to the atypical early symptoms and characteristics of HCC, over 80% of HCC patients cannot receive curative treatment. The treatment of...
Saved in:
Main Authors: | Zhongyuan Yang, Wenjiao Chen, Yunhui Liu, Yuxin Niu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Infectious Agents and Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13027-024-00630-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Should We Adopt Increased Dilutions for Indirect Immunofluorescence in Pediatric Anti-Centromere Antibody Testing? Insights from a Three-Year Retrospective Study
by: Mehmet Soylu, et al.
Published: (2024-12-01) -
New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy
by: Mengran Li, et al.
Published: (2025-01-01) -
Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma
by: Hezhou Long, et al.
Published: (2025-01-01) -
The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights
by: Valentina Arrè, et al.
Published: (2025-01-01) -
HP1 Promotes the Centromeric Localization of ATRX and Protects Cohesion by Interfering Wapl Activity in Mitosis
by: Erchen Zhang, et al.
Published: (2025-01-01)